Del. Jury Says NanoString Owes $31M In 10x Patent Spat
A Delaware federal jury on Friday determined that Seattle-based NanoString Technologies Inc. willfully infringed several gene technology patents exclusively licensed to 10x Genomics and awarded more than $31 million in damages,...To view the full article, register now.
Already a subscriber? Click here to view full article